Sculptor Diversified Real Estate Income Trust, Inc. (SDREIT) - Annual Guide

I’ve put together this guide to help you understand how Sculptor Diversified Real Estate Income Trust (SDREIT) operates. My goal is to explain their filings in plain English so you can decide if this investment fits your goals.

1. What does this company do?

Think of SDREIT as a real estate collector. They own a wide variety of properties, including homes, student housing, warehouses, hotels, offices, and storage facilities. They hold about 140 properties. They also act as a lender to other real estate firms, with a loan portfolio worth roughly $250 million. Sculptor Capital Management, a firm managing over $30 billion in assets since 2003, manages the trust.

2. The "Big Picture" for Investors

SDREIT is a non-traded REIT. You cannot buy or sell these shares on a public stock exchange. Your money is effectively locked in. While they have a share buyback program, they limit repurchases to 5% of their total shares per year. Furthermore, the board is not required to fulfill these requests if they lack the cash or decide it isn't in the company's best interest. This is a long-term, illiquid investment.

3. How they make money (and the risks involved)

SDREIT aims to pay regular cash distributions, typically targeting a 5-6% annual yield based on their net asset value. However, these payments are not guaranteed. Crucially, they may pay you using money from sources other than rental profits, such as taking on new debt or using cash from new investors. Recently, 20-30% of distributions came from these outside sources. This practice can limit the company's growth or lower the value of your shares over time.

4. Key Risks: What could go wrong?

• "Paper" Value vs. Reality: The value per share was $8.10 at the end of 2025, down from $8.31 in 2024. You likely start your investment "underwater" because the purchase price includes upfront sales fees of up to 4%.
• Concentration Risk: A massive 38% of their revenue comes from one tenant, "Sevita." If this healthcare company struggles or leaves, it would significantly hurt SDREIT’s ability to pay you.
• The "CapGrow" Conflict: SDREIT bought a company called CapGrow from a party related to their own leadership for $450 million. Because no independent directors oversaw this deal, there is a risk they overpaid to justify higher management fees.
• Debt & Lending Dangers: The company carries a high debt-to-asset ratio of about 60%. This creates several traps:
  • Personal Liability: If the company breaks loan rules, management could be personally responsible for the full loan, putting your investment at risk.
  • Interest Rates: About 45% of their debt has variable rates. If rates rise by 1%, their annual interest costs jump by $2.2 million, leaving less profit for you.
  • Lender Control: Lenders can stop your distributions if the company fails to meet specific financial health requirements.
  • Balloon Payments: Over $150 million in debt is due within two years. If they cannot refinance or sell these properties, the fund could face a financial crisis.
• The "Founding Investor" Power: One investor owns 48% of the company. They can outvote everyone else, and their goals may not match yours.
• Management Conflicts: You pay fees that were not negotiated independently. Management earns a fee based on the total size of the fund, not your profit. This encourages them to grow the fund through debt rather than focusing on your returns.

Final Thought for Your Decision: When considering this investment, ask yourself if you are comfortable with the lack of liquidity and the reliance on debt to fund distributions. Because this is a non-traded vehicle with significant management conflicts and high concentration in a single tenant, it is important to weigh the potential yield against the risk that your capital may be tied up for a long time without the ability to easily exit.